Esonide – back in stock
Actavis
Actavis would like to inform the you that Esonide is back in stock.
Esonide contains Budesonide 2 mg /ml (100 μg/dose) and is a metered dose nasal spray. It is used in:
–the treatment of seasonal or chronic allergic rhinitis in adults and children (≥6 years old) and chronic non allergic rhinitis in adults.
– the treatment of nasal obstruction related to nasal polyps in adults.
Dosage Regimen |
|||
Seasonal or chronic allergic rhinitis |
Adults, elderly and children over 6 years of age |
200µg (2 sprays) into each nostril in the morning or 100µg (1 spray) into each nostril twice daily |
|
Chronic non-allergic rhinitis |
|||
Nasal obstruction to nasal polyps |
|||
200µg (2 sprays) twice daily for a period of up to 3 months |
Related Posts
Please login to access this information.
Tags
adoloscence
cancer
cannabis
Cardiology
Contributions
covid 19
dementia
Dermatology
Dermfest
Diabetes
Editorial
endocrinology
environmental health
exercise
Family Medicine
Francesco Carelli
gastroenterology
Geriatrics
gynaecology
hypertension
Infectious Diseases
Medical Education
Medical Ethics
Medicine and the arts
microbionta
Neurology
Nutrition
obesity
obstetrics
Oncology
Orthopaedics
Paediatrics
Pharmacology
Pharmacy Practice
pregnancy
Psychiatry
Public Health
Radiology
Respiratory Medicine
Rheumatology
smoking
Surgery
TheSynapse Interview
Urology
Women's health